Related Experiment Videos
Psoriasiform eruption from intramuscular botulinum A toxin
1Department of Dermatology, University of Texas Medical School, Houston 77030.
Cutis
|December 1, 1992
Summary
Botulinum A toxin injections, commonly used for muscle disorders and cosmetic treatments, can rarely cause skin reactions. This report details a unique case of psoriasiform eruption following botulinum toxin therapy for an eye muscle condition.
Area of Science:
- Dermatology
- Ophthalmology
- Neurology
Background:
- Botulinum A toxin is a widely used therapeutic agent for various neuromuscular disorders and cosmetic applications.
- Its efficacy in treating conditions like spasticity, strabismus, and glabellar furrows is well-established, with effects lasting several months.
- Systemic side effects are infrequent and typically resolve quickly.
Observation:
- A patient developed a psoriasiform eruption.
- This skin condition emerged temporally after receiving botulinum A toxin injections.
- The injections were administered into the medial rectus muscle to address an ocular motility disorder.
Findings:
- This case represents the first documented instance of a psoriasiform dermatitis linked to botulinum A toxin administration.
- The adverse skin reaction was directly associated with the therapeutic use of botulinum A toxin.
Implications:
- The findings suggest a potential, albeit rare, dermatological side effect of botulinum A toxin.
- Clinicians should be aware of the possibility of psoriasiform eruptions in patients treated with botulinum A toxin.
- Further investigation may be warranted to understand the mechanism behind this adverse reaction.